A supplement can contain the correct quantity of an ingredient and still face challenges in releasing that ingredient from its dosage form.
For this reason, product development cannot focus exclusively on what goes into a tablet or capsule. It must also consider how the finished dosage form behaves under defined testing conditions.
Dissolution testing is one method used to investigate that behaviour.
Disintegration refers to the breakup of a dosage form into smaller particles or components under specified conditions.
Dissolution refers to the process by which a substance enters solution.
A tablet may disintegrate without all of its ingredients dissolving rapidly. Similarly, the dissolution characteristics of an ingredient depend on its solubility, particle properties, formulation, and test environment.
For nutraceutical contract manufacturers, distinguishing between these processes is important when developing meaningful product specifications.
Several formulation variables can affect how a supplement performs during testing.
Particle size may influence the available surface area for dissolution. The chemical form of a mineral or vitamin may affect its solubility, while excipients can influence wetting, dispersion, and the physical structure of a tablet.
Compression force is another consideration.
Excessive tablet hardness may slow liquid penetration or disintegration in certain formulations, although the relationship depends on the materials and manufacturing process.
Coatings can also influence release behaviour, particularly when they are designed for a specific functional purpose.
A dissolution result should therefore be interpreted in the context of the formulation and the intended product characteristics.
Dissolution results depend on the method used.
Variables such as test medium, pH, agitation, temperature, and sampling intervals can affect the observed release profile.
A method suitable for one ingredient or dosage form may not be appropriate for another.
Furthermore, dissolution testing does not automatically establish how much of an ingredient will be absorbed by the human body. Biological availability involves additional factors, including digestion, transport, metabolism, and the characteristics of the nutrient itself.
Liquid-filled capsules introduce additional considerations.
With softgel manufacturing services, formulators may need to evaluate shell rupture, fill dispersion, and the behaviour of the active ingredient once the contents are released.
Oil-based ingredients may require different analytical approaches from readily water-soluble compounds.
Shell composition, fill viscosity, and interactions between the formulation and test medium can influence the results.
These factors highlight why release testing should be designed around the actual product rather than relying on a single universal method.
When a product does not meet its intended release characteristics, formulators can investigate ingredient properties, excipient selection, processing parameters, and dosage-form design.
Testing during development can help identify potential issues before commercial-scale production.
Dissolution testing provides useful information about how a finished supplement releases its ingredients under controlled conditions.
Its value lies in supporting formulation decisions, identifying inconsistencies, and improving product understanding—not in making unsupported claims about absorption or clinical effectiveness.
Partner with excellence. Launch your branded supplements today.
India’s trusted CDMO Partner, delivering science-driven solutions across healthcare & cosmetics sectors.
© 2026 H&H Healthcare and Cosmetics Pvt. Ltd. Designed by ROI Makers.